RFA
EBS icon

Register Financial Advisors’s Emergent Biosolutions EBS Stock Holding History

Register Financial Advisors’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-200
Closed -$1.36K – 423
2024
Q2 		$1.36K Hold
200
– – ﹤0.01% 681
2024
Q1 		$506 Buy
+200
New +$451 ﹤0.01% 717
2023
Q4 		– Sell
-200
Closed -$680 – 399
2023
Q3 		$680 Hold
200
– – ﹤0.01% 562
2023
Q2 		$1.47K Hold
200
– – ﹤0.01% 508
2023
Q1 		$2.07K Hold
200
– – ﹤0.01% 492
2022
Q4 		$2.36K Buy
+200
New +$3.1K ﹤0.01% 730

Other funds holding EBS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OHA
Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Register Financial Advisors's EBS Position: Q3 2024 in Review

Register Financial Advisors sold out of Emergent Biosolutions (EBS) in Q3 2024, closing a stake of 200 shares — an estimated $1.36K sold.

Register Financial Advisors first reported a position in EBS in Q4 2022 and held it in 6 quarters. The position peaked at $2.36K in Q4 2022. 140 funds tracked by Wall St. Rank hold EBS as of Q3 2024.

  • Register Financial Advisors reported no remaining Emergent Biosolutions position as of Q3 2024 after selling out during the quarter.
  • Register Financial Advisors sold 200 Emergent Biosolutions shares in Q3 2024, an estimated $1.36K.
  • Register Financial Advisors first reported a position in Emergent Biosolutions in Q4 2022 and held it in 6 quarters.
  • Register Financial Advisors's Emergent Biosolutions position peaked at $2.36K in Q4 2022.
  • 140 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2024.

Based on Register Financial Advisors's 13F filing for Q3 2024, filed 15 Oct 2024.